Eating Disorders

Anorexia nervosa drug pipeline

  • ICD-11 6B80
  • MeSH D000856

1 compound from 1 company is in active clinical development for anorexia nervosa.

1Compound
1Company
0Phase 3+
14Trials recruiting

Mechanisms: Psychedelic (1)

Pipeline data compiled September 2026 · every fact sourced.

Upcoming readouts & recent results

  • 2025-08-01ReportedPsilocybin (COMP360)Topline datamixedNCT05481736

    Phase 2 anorexia PoC (NCT05481736, n=32): encouraging improvement in eating-disorder symptoms sustained through 12 weeks on 25mg, but underpowered with heavy control-arm dropout

See the full catalyst calendar →

Compounds in development (1)

CompoundCompanyPhaseStatusMechanism
Psilocybin (COMP360)COMPASS Pathways plcPhase 2Completed5-HT2A Partial agonist

Trials recruiting now (12)

12 drug-interventional anorexia nervosa trials recruiting now, of 63 registered interventional trials. Browse all on ClinicalTrials.gov →

Frequently asked

How many drugs are in development for anorexia nervosa?
1 compound from 1 company is in active clinical development for anorexia nervosa.
How many clinical trials are recruiting for anorexia nervosa?
12 drug-interventional anorexia nervosa trials are currently recruiting participants, out of 63 registered interventional trials.